TCR2 THERAPEUTICS INC. insider trading activity

Understanding Insider Activity at TCR2 THERAPEUTICS INC.

Welcome to our dedicated page for TCR2 THERAPEUTICS INC. (Nasdaq: TCRR) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by TCR2 THERAPEUTICS INC.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for TCR2 THERAPEUTICS INC., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for TCRR
TickerTime & DateFilingLink
TCRR12:02:28 AM, 05/31/2023
TANG KEVIN C purchased 50000 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$86000
Filing
TCRR08:39:01 PM, 05/24/2023
MPM ASSET MANAGEMENT LLC sold 70170 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$131919
Filing
TCRR08:38:19 PM, 05/24/2023
GADICKE ANSBERT sold 70170 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$131919
Filing
TCRR09:12:15 PM, 05/15/2023
TANG KEVIN C purchased 44948 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$87647
Filing
TCRR11:02:43 PM, 05/10/2023
TANG KEVIN C purchased 83988 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$163775
Filing
TCRR10:52:56 PM, 05/05/2023
TANG KEVIN C purchased 289577 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$547943
Filing
TCRR01:26:27 AM, 12/14/2022
Cardama Alfonso Quintas(Chief Medical Officer) sold 13799 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$15121
Filing
TCRR01:24:08 AM, 12/14/2022
Olagunju Peter(Chief Technical Officer) sold 4830 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$5292
Filing
TCRR01:21:29 AM, 12/14/2022
Justice Angela(Chief People Officer) sold 8620 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$9445
Filing
TCRR01:19:57 AM, 12/14/2022
Menzel Garry E(President and CEO) sold 31938 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$35001
Filing
TCRR09:53:38 PM, 12/09/2022
Cardama Alfonso Quintas(Chief Medical Officer) sold 7942 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$10084
Filing
TCRR09:44:15 PM, 12/09/2022
Menzel Garry E(President and CEO) sold 18425 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$23304
Filing
TCRR09:43:47 PM, 12/09/2022
Justice Angela(Chief People Officer) sold 4968 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$6282
Filing
TCRR09:42:39 PM, 12/09/2022
Olagunju Peter(Chief Technical Officer) sold 2788 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$3525
Filing
TCRR12:56:51 AM, 12/08/2022
Cardama Alfonso Quintas(Chief Medical Officer) sold 7464 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$10073
Filing
TCRR12:56:09 AM, 12/08/2022
Olagunju Peter(Chief Technical Officer) sold 2618 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$3532
Filing
TCRR12:56:04 AM, 12/08/2022
Menzel Garry E(President and CEO) sold 23416 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$31782
Filing
TCRR12:54:31 AM, 12/08/2022
Justice Angela(Chief People Officer) sold 4663 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$6293
Filing
TCRR12:52:37 AM, 12/06/2022
Cardama Alfonso Quintas(Chief Medical Officer) sold 3636 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$5054
Filing
TCRR12:50:38 AM, 12/06/2022
Olagunju Peter(Chief Technical Officer) sold 1273 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$1769
Filing
TCRR12:49:20 AM, 12/06/2022
Menzel Garry E(President & CEO) sold 8408 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$11687
Filing
TCRR12:45:34 AM, 12/06/2022
Justice Angela(Chief People Officer) sold 2273 shares of TCR2 THERAPEUTICS INC. (TCRR) for ~$3159
Filing

Discover the Complete Picture 🔒

Currently viewing just 6 of 22 insider filings.
Register now to dive deeper and explore the full dataset.